Ortho Evra (norelgestromin/ethinyl estradiol)
Prescribing information updated to include the findings of two epidemiology studies that evaluated the risk of women using Orthro Evra developing serious blood clots.


« GlaxoSmithKline Seeks U.S. Approval for Tykerb(R) (Lapatinib Ditosylate) for the Treatment of Advanced Breast Cancer | Main | FDA Statement on Foodborne E. coli O157:H7 Outbreak in Spinach; Update (Tuesday, September 19) »
Prescribing information updated to include the findings of two epidemiology studies that evaluated the risk of women using Orthro Evra developing serious blood clots.
The comments to this entry are closed.
Comments